CMS Open Payments · Program Year 2024
Minerva Surgical, Inc
Minerva Surgical, Inc reported $53,864.91 across General Payments, Research, and Ownership to 1,260 physicians and teaching hospitals across 1,260 transactions.
- $53.9K Below-median payer
- All-tracks total
- 1,260 Above-median volume
- Transactions
- 1,260 Top quartile reach
- Recipients
- −$38.7K
- General Payments vs PY2023
Minerva Surgical, Inc reported $53,864.91 across all CMS Open Payments tracks (General + Research + Ownership) to 1,260 physicians and teaching hospitals in Program Year 2024 - ranking #1332 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $53,864.91, averaging $42.75 per recipient.
Minerva Surgical, Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
25/100
Total payments
F
10/100
Transaction volume
F
19/100
Physician reach
F
20/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer minerva-surgical-inc Minerva Surgical, Inc
$53.9K · #1332/1,925 · 0.0% industry · PY2024
- TOT $53.9K
- RANK #1332
- SHARE 0.0%
- TXN 1,260
- RCP 1,260
- CAT 4
- GEN $53.9K
- ΔGEN −$38.7K
- TOP1 21.0%
- PY 2024
Volume peers
Nearest volume peer: Werfen USA LLC ($53.8K)
Minerva Surgical, Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Minerva Surgical, Inc's CMS-reported General Payments decreased by $38.7K (−41.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MINERVA SURGICAL, INCPY2023: MINERVA SURGICAL, INCPY2024: Minerva Surgical, Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $92,576.87
- PY2024
- $53,864.91
What the Data Shows for Minerva Surgical, Inc
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Minerva Surgical, Inc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 4 general-payment categories charted below, "Food and Beverage" is the largest at $38.9K across 1,242 transactions, 72.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads Minerva Surgical, Inc's 4-category general-payment breakdown at $38.9K, 72.3% of the reported total.
Minerva Surgical, Inc reports 4 general-payment categories - the top three are Food and Beverage (72.3%), Compensation for Services Other Than Consulting (15.3%), and Consulting Fee (7.0%). The remaining 1 category make up 5.5% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Minerva Surgical, Inc divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $38.9K | 1,242 | 72.3% |
| Compensation for Services Other Than Consulting | $8.2K | 7 | 15.3% |
| Consulting Fee | $3.8K | 3 | 7.0% |
| Travel and Lodging | $3.0K | 8 | 5.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $17,804.57 (33.1%) of $53,864.91 in this company's General Payments records across 987 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Minerva Surgical, Inc
The five named recipients with the highest reported General Payments from this company
- 1
Soheil Amin Hanjani
$11,308.81 across 29 reported transactions
- 2
Stephanie Ellen Rajchel
$3,213.96 across 6 reported transactions
- 3
David I Glassman
$1,897.89 across 13 reported transactions
- 4
Carlos M Guevara
$707.02 across 15 reported transactions
- 5
Micah Wright
$676.89 across 15 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Minerva Surgical, Inc's spend rank (#1332 of 1,925, bottom 31% by spend) and concentration rank (#1,289 of 1,838, bottom 30% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Heron Therapeutics, Inc. : $907.0K total payments, HHI 510
- ITF Therapeutics LLC : $67.9K total payments, HHI 510
- Active Medical, LLC : $34.6K total payments, HHI 509
- Insight Medical Systems, Inc. : $174.6K total payments, HHI 507
- CoapTech, Inc. : $4.0K total payments, HHI 506
- Otter Pharmaceuticals, LLC : $86.2K total payments, HHI 504
- Minerva Surgical, Inc (this company) : $53.9K total payments, HHI 503
- Sterilmed, Inc. : $263.8K total payments, HHI 500
- Merge Healthcare Incorporated : $6.9K total payments, HHI 499
- Alnylam Pharmaceuticals Inc. : $6.5M total payments, HHI 498
- Nxstage Medical, Inc. : $106.2K total payments, HHI 496
- Adaptive Biotechnologies Corporation : $462.3K total payments, HHI 495
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Minerva Surgical, Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Minerva Surgical, Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Minerva Surgical, Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Integer Holdings Corporation
Pierre Fabre Pharmaceuticals, Inc.
Eisai Co., Ltd.
Sioux Surgical Inc
On Target Laboratories, Inc
Put this to use
Minerva Surgical, Inc ranks #1332 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Minerva Surgical, Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.